Erste Asset Management’s IVERIC bio ISEE Stock Holding History
Bought
Maintained
Sold
Erste Asset Management's ISEE Position: Q3 2023 in Review
Erste Asset Management sold out of IVERIC bio (ISEE) in Q3 2023, closing a stake of 66,300 shares — an estimated $2.59M sold.
Erste Asset Management first reported a position in ISEE in Q1 2022 and held it in 6 quarters. The position peaked at $2.59M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.
- Erste Asset Management reported no remaining IVERIC bio position as of Q3 2023 after selling out during the quarter.
- Erste Asset Management sold 66,300 IVERIC bio shares in Q3 2023, an estimated $2.59M.
- Erste Asset Management first reported a position in IVERIC bio in Q1 2022 and held it in 6 quarters.
- Erste Asset Management's IVERIC bio position peaked at $2.59M in Q2 2023.
- 0 funds tracked by Wall St. Rank held IVERIC bio as of Q3 2023.
Based on Erste Asset Management's 13F filing for Q3 2023, filed 26 Nov 2024.